# The Drug Repurposing Market to virtually grow beyond geographies
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-12-13
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Revolutionising Healthcare: Drug Repurposing Market Trends
Meta Description: Discover how drug repurposing is revolutionising the healthcare sector, creating cost-effective solutions and new treatment options for patients.
URL: https://financedigest.com/the-drug-repurposing-market-to-virtually-grow-beyond-geographieshtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836592194-compressed.jpg)

The Drug Repurposing Market is all set to be in the driver’s seat shortly. Technology adoption once looked upon as a costly endeavor, is slated to witness a drastic transformation in the form of granular applications. [Technologies like DevOps and AIOps are constructively disrupting the healthcare IT sector](https://www.financedigest.com/how-video-technology-continues-to-boom-in-the-education-sector.html "How video technology continues to boom in the education sector") and are expected to create wonders in this regard in the upcoming period.

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and [biopharmaceutical](https://www.persistencemarketresearch.com/market-research/biopharmaceutical-market.asp) companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned.

National Institute of Health (NIH), U.S. [Department of Health](https://www.financedigest.com/baswares-e-invoicing-to-eliminate-inefficiencies-in-health-department.html "Basware’s e-invoicing to eliminate inefficiencies in Health Department") defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing [opens up various opportunities to answer current](https://www.financedigest.com/more-than-half-of-workers-are-open-to-leaving-their-current-employers.html "MORE THAN HALF OF WORKERS ARE OPEN TO LEAVING THEIR CURRENT EMPLOYERS") unmet medical needs to come up with cost-effective solutions to expensive drug development process.

Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by [saving time and money](https://www.financedigest.com/how-to-save-money-for-a-car.html "How to save money for a car") while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for [anti-cancer](https://www.persistencemarketresearch.com/market-research/anticancer-drugs-market.asp) activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies.

**Get Sample Copy of this Report@** [**https://www.persistencemarketresearch.com/samples/14347**](https://www.persistencemarketresearch.com/samples/14347)

However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for [breast cancer treatment](https://www.persistencemarketresearch.com/market-research/breast-cancer-treatment-market.asp)), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

Requirement of low investment of time and money in the [drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline](https://www.financedigest.com/gsk-bets-2-billion-on-bellus-cough-drug-to-soothe-pipeline-fears.html "GSK bets billion on Bellus cough drug to soothe pipeline fears") of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to [drive the global drug repurposing market](https://www.financedigest.com/increasing-incidences-of-spinal-fractures-to-drive-the-osteoporosis-drugs-market.html "Increasing incidences of spinal fractures to drive the Osteoporosis Drugs Market").

There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure [data of drug](https://www.financedigest.com/interoperability-of-data-to-accelerate-the-us-animal-drug-compounding-market.html "Interoperability of data to accelerate the US Animal Drug Compounding Market") molecules, lack of funding etc. are some of the factors limiting the growth of global [drug repurposing market](https://www.financedigest.com/the-peptic-ulcer-drugs-market-to-proliferate-with-digitized-upswing.html "The Peptic Ulcer Drugs Market to proliferate with digitized upswing").

Patent-cliff and drug attrition rate are the major [challenge for pharmaceutical and healthcare industry](https://www.financedigest.com/cup-holder-market-emerging-industries-challenges-and-threats-faced-by-key-vendors-and-global-business-outlook-till-2031.html "Cup Holder Market Emerging industries, Challenges and Threats Faced by Key Vendors and Global Business Outlook till 2031"), putting huge pressure on pipeline. Today’s industry also [faces considerable competition from generic versions of off-patent drugs](https://www.financedigest.com/bristol-myers-pfizer-abbvie-drugs-likely-to-face-u-s-price-negotiation.html "Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation"). Repurposing thus gives a major hope for the pipeline growth and [future of healthcare](https://www.financedigest.com/the-future-of-healthcare.html "The future of healthcare") industry. This also provides legacy of out-licensing clinical candidates that have been proven save but could not met the [end point](https://www.financedigest.com/ecb-goes-big-with-50-basis-point-hike-ending-negative-rates-era.html "ECB goes big with 50 basis-point hike, ending negative rates era").

**Request for Table of Content@** [**https://www.persistencemarketresearch.com/toc/14347**](https://www.persistencemarketresearch.com/toc/14347)

The [global market](https://www.financedigest.com/entering-the-global-market-a-strategy-for-the-new-year-and-beyond.html "Entering the global market: a strategy for the New Year and beyond") for drug repurposing is segmented on basis of disease indication and geography:

- Segmentation by Disease Indication
  - Oncology
  - CNS Diseases
  - Neurodegenerative diseases
  - Other ( [autoimmune diseases](https://www.financedigest.com/digital-dissertation-to-drive-the-autoimmune-disease-diagnostics-market.html "Digital dissertation to drive the Autoimmune Disease Diagnostics Market"), Leishmaniasis etc.)

Oncology holds the highest growth potential in the global drug repurposing [market as there is significant unmet need](https://www.financedigest.com/why-markets-need-a-players-more-than-ever-before.html "Why markets need A-Players more than ever before") for cancer treatment and divergent nature of a disease. On the basis of regional presence, [global drug repurposing market](https://www.financedigest.com/global-anisole-market.html "Global Anisole Market") is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and [Middle East](https://www.financedigest.com/stanchart-sees-asia-middle-east-as-bright-spots-in-weak-global-economy.html "StanChart sees Asia, Middle East as bright spots in weak global economy") & Africa. North America is [expected to lead the global market due to strong](https://www.financedigest.com/ea-lowers-bookings-expectation-on-strong-dollar-gaming-slowdown.html "EA lowers bookings expectation on strong dollar, gaming slowdown") funding sources for drug repurposing such as NIH’s National Center for Advancing Translational Sciences.

Companies operating in pharmaceutical market are exploiting drug repurposing [strategy](https://www.financedigest.com/beyond-the-pill-strategy-to-be-the-centerpoint-of-facial-skincare-market.html "“Beyond the Pill” Strategy to be the CenterPoint of Facial Skincare Market") to protect the market exclusivity of their blockbuster molecules. Several big pharmaceutical [companies like Sanofi are forming venture with medium to small scale companies for use of their repurposing platform to find alternative](https://www.financedigest.com/closing-a-limited-company-three-alternatives-to-liquidation.html "Closing a limited company: three alternatives to liquidation") use for clinical-stage molecules.

Some of the other players operating in [global drug repurposing market](https://www.financedigest.com/global-sweetener-market-reaching-nearly-us-160-bn-by-2027.html "Global Sweetener Market reaching nearly US$ 160 Bn by 2027") are Astellas Pharma Inc., Biovista, Novartis AG, AbbVie Inc., Pfizer Inc., Allergan Plc., NuMedii and others. [Companies are also maintaining external partnerships in drug](https://www.financedigest.com/immunology-drug-market-growth-by-top-companies-trends-by-types-and-application-forecast-analysis-to-2030.html "Immunology Drug Market Growth by Top Companies, Trends by Types and Application, Forecast Analysis to 2030") repurposing. Private foundations and [clinical research organizations are also entering into drug repurposing market](https://www.financedigest.com/the-clinical-nutrition-market-to-escalate-on-a-holistic-note.html "The Clinical Nutrition Market To Escalate On A Holistic Note").

**Access Full Report@** [**https://www.persistencemarketresearch.com/checkout/14347**](https://www.persistencemarketresearch.com/checkout/14347)

**About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact Us:**

**Persistence** [Market Research](https://www.financedigest.com/brachytherapy-devices-market-growing-at-a-cagr-of-8-1-and-to-target-us-1613-6-million-by-2026-transparency-market-research.html "Brachytherapy Devices Market Growing at a CAGR of 8.1% and to Target US$ 1,613.6 Million by 2026 | Transparency Market Research")

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Japan Office:** [1-2-1 Kinshi Arca Central Building](https://www.financedigest.com/ireland-to-turn-heat-down-in-public-buildings-shut-empty-office-floors.html "Ireland to turn heat down in public buildings, shut empty office floors")

14/F Tokyo, 130-0013, Japan

Call 1-888-863-3700

**Sales** – sales@persistencemarketresearch.com

**Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---